UNSPSC 85704913: Revision of autologous tissue substitute in left tarsal, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left tarsal, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QWMX7Z

UNSPSC 85704913 Revision of autologous tissue substitute in left tarsal, external approach is a Commodity code whose nominal title describes a surgical procedure, yet the recent state and local opportunities tagged under it do not involve tissue substitutes, surgical revision, or tarsal procedures. The code shows little relevant recent activity aligned with its stated scope. The six opportunities posted since July 2026 span independent medical evaluation services for pension disability determinations, surgical care networks and Centers of Excellence, occupational medical surveillance for ferry workers, emergency and specialty care for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve autologous tissue revision or orthopedic implant procedures. This mismatch suggests either miscoding in the source data or a fundamental disconnect between the code's clinical descriptor and how state and local procurement offices are actually using it.

The issuing bodies range across city retirement offices, municipal human resources departments, state transportation agencies, county health systems, and county probation departments — a mix of administrative health plan procurement, occupational health compliance, and clinical service contracting rather than surgical implant or tissue-substitute supply. The geographic spread includes Arizona, California, Washington, Texas, and Florida. Without opportunities that reflect the code's nominal scope, business development professionals should verify whether this code is genuinely in use for autologous tissue procurement in state and local contexts or whether the tagging reflects data quality issues upstream.